• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Bowen Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    6/27/25 4:00:41 PM ET
    $BOWN
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $BOWN alert in real time by email
    false 0001973056 0001973056 2025-06-26 2025-06-26 0001973056 BOWN:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2025-06-26 2025-06-26 0001973056 BOWN:OrdinarySharesParValue0.0001PerShareMember 2025-06-26 2025-06-26 0001973056 BOWN:RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember 2025-06-26 2025-06-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): June 26, 2025

     

    BOWEN ACQUISITION CORP

    (Exact Name of Registrant as Specified in Charter)

     

    Cayman Islands   001-41741   N/A 00-0000000
    (State or Other Jurisdiction   (Commission   (IRS Employer
    of Incorporation)   File Number)   Identification No.)

     

    420 Lexington Ave, Suite 2446

    New York, NY 10170

    (Address of Principal Executive Offices) (Zip Code)

     

    (203) 998-5540

    (Registrant’s Telephone Number, Including Area Code)

     

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

      ☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
         
      ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
         
      ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
         
      ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

     

    Securities registered pursuant to section 12(b) of the Act:

     

    Title of Each Class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one ordinary share and one right   BOWNU   The Nasdaq Stock Market LLC
             
    Ordinary Shares, par value $0.0001 per share   BOWN   The Nasdaq Stock Market LLC
             
    Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination   BOWNR   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    On June 26, 2025, Bowen Acquisition Corp, a Cayman Islands exempted company (the “Company”), entered into a second amendment (the “Amendment”) to the previously disclosed Agreement and Plan of Reorganization, dated as of January 18, 2024 and amended on March 21, 2025 (“Merger Agreement”), by and among the Company, Bowen Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of the Company (“Merger Sub”), Shenzhen Qianzhi BioTechnology Co. Ltd., a company incorporated in the People’s Republic of China and a wholly owned subsidiary of NewCo (as defined below) (“Qianzhi”), and Qianzhi Group Holding (Cayman) Limited, a newly formed Cayman Islands company (“NewCo”). As previously disclosed, the Merger Agreement contemplates that Merger Sub will merge with and into NewCo, with NewCo being the surviving company of the merger and becoming a wholly owned subsidiary of the Company.

     

    The Amendment extends the outside date by which the parties must consummate the Merger Agreement to December 14, 2025.

     

    The foregoing description of the Amendment is qualified in its entirety by reference to the text of the Amendment, a copy of which is attached as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits:

     

    Exhibit   Description
         
    2.1   Amendment No. 2 to Agreement and Plan of Reorganization
    104   Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

     

     

     

     

    Cautionary Note Regarding Forward Looking Statements

     

    Neither the Company nor any of its affiliates makes any representation or warranty as to the accuracy or completeness of the information contained in this Current Report on Form 8-K. This Current Report on Form 8-K is not intended to be all-inclusive and is not intended to form the basis of any investment decision or any other decision in respect of the Company or the proposed business combination with NewCo and Qianzhi.

     

    This Current Report on Form 8-K include “forward-looking statements” made pursuant to the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements generally are identified by the words or phrases such as “aspire,” “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “will be,” “will continue,” “will likely result,” “could,” “should,” “believe(s),” “predicts,” “potential,” “continue,” “future,” “opportunity,” seek,” “intend,” “strategy,” or the negative version of those words or phrases or similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s expectations with respect to future performance and anticipated financial impacts of the proposed business combination with NewCo and Qianzhi.

     

    The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

     

    No Offer or Solicitation

     

    This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: June 27, 2025  
         
      By: /s/ Jiangang Luo
        Jiangang Luo
        Chief Executive Officer

     

     

    Get the next $BOWN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BOWN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BOWN
    SEC Filings

    See more
    • Bowen Acquisition Corp filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Bowen Acquisition Corp (0001973056) (Filer)

      7/11/25 4:30:33 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 8-K filed by Bowen Acquisition Corp

      8-K - Bowen Acquisition Corp (0001973056) (Filer)

      7/11/25 4:30:13 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 10-Q filed by Bowen Acquisition Corp

      10-Q - Bowen Acquisition Corp (0001973056) (Filer)

      7/8/25 4:30:37 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary

    $BOWN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nasdaq Halts Bowen Acquisition Corp.

      NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading was halted on July 15, 2025 in Bowen Acquisition Corp. at 17:45:19 Eastern Time for additional information requested from the company. The last sale price of the company's securities was: Ordinary shares (NASDAQ:BOWN) $9.19Rights (NASDAQ:BOWNR) $0.2252Units (NASDAQ:BOWNU) $13.02 Trading will remain halted until Bowen Acquisition Corp. has fully satisfied Nasdaq's request for additional information. For news and additional information about the company, please contact the company directly or check under the company's symbol using InfoQuotesSM on the Nasdaq® Web site. For more inform

      7/16/25 4:05:00 PM ET
      $BOWN
      $NDAQ
      Package Goods/Cosmetics
      Consumer Discretionary
      Investment Bankers/Brokers/Service
      Finance
    • Bowen Acquisition Corp Receives NASDAQ Notification of Non-Compliance with Listing Rules

      New York, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ:BOWN) ("BOWN"), a special purpose acquisition company, announced that on May 28, 2025, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("NASDAQ") advising the Company that the Company does not comply with NASDAQ's Listing Rule 5250(c)(1) for continued listing because NASDAQ has not received the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the "Form 10-Q"). NASDAQ has informed the Company that it has until July 28, 2025 to submit a plan to regain compliance with respect to this delinquent report. If NASDAQ approves the Company's pla

      5/29/25 4:30:00 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company

      New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ:BOWN) ("BOWN"), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the "Merger Agreement") with Shenzhen Qianzhi BioTechnology Co., Ltd ("Qianzhi BioTech"), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China. Pursuant to the Merger Agreement, BOWN's wholly owned subsidiary, Bowen Merger Sub, a Cayman Islands exempted company, will merge (the "Merger" or the "Business Combination") with and into Qianzhi Group Holding (Cayman) Limited, parent of Qianzhi BioTech and an exempted company incorporated with

      1/18/24 7:00:00 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary

    $BOWN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Harraden Circle Investments, Llc sold $65,822 worth of Ordinary Shares (5,432 units at $12.12) (SEC Form 4)

      4 - Bowen Acquisition Corp (0001973056) (Issuer)

      5/14/25 8:00:09 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Large owner Harraden Circle Investments, Llc sold $33,699 worth of Ordinary Shares (2,800 units at $12.04) (SEC Form 4)

      4 - Bowen Acquisition Corp (0001973056) (Issuer)

      5/13/25 8:00:10 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Large owner Harraden Circle Investments, Llc sold $64,923 worth of Ordinary Shares (5,376 units at $12.08) (SEC Form 4)

      4 - Bowen Acquisition Corp (0001973056) (Issuer)

      5/12/25 8:00:05 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary

    $BOWN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Bowen Acquisition Corp

      SC 13G - Bowen Acquisition Corp (0001973056) (Subject)

      11/14/24 4:52:26 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G filed by Bowen Acquisition Corp

      SC 13G - Bowen Acquisition Corp (0001973056) (Subject)

      11/14/24 10:31:35 AM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Bowen Acquisition Corp

      SC 13G/A - Bowen Acquisition Corp (0001973056) (Subject)

      11/12/24 4:01:57 PM ET
      $BOWN
      Package Goods/Cosmetics
      Consumer Discretionary